MARKET PROSPECTS
The EU is Malaysia's fifth largest trading partner (after China, Singapore, SKorea & US)
MALAYSIA's healthcare expenditures are forecast to double to $28 bil by 2028, growing annualy by 7%. Healthcare delivery is evenly split between the private and public sectors, and the country aims to be a top medical travel destination., with pre-COVID visitors totaling over one million and revenues of $433 million in 2019.
Providers are planning to offer best-in-class medical treatments by innovating and digitizing their healthcare infrastructure.
Specialised treatments represent additional areas of opportunity, including fertility, oncology and cardiology.
Request more specific information from ABCEx.